Dogwood Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -17 | -17 | -12 | |
EBITDA | -3,789 | -10,570 | -7,572 | -2,301 |
EBIT | -3,807 | -10,587 | -7,542 | -2,301 |
Net Income | -3,807 | -10,924 | -7,727 | -2,280 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,026 | -4,682 | -6,131 | -910 |
Cash | 13,402 | 17,539 | 14,847 | 2,039 |
Basic Shares | 1,911 | 1,441 | 1,310 | 1,110 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -12 | |||
EBITDA | -12,245 | -5,446 | -12,315 | -15,640 |
EBIT | -12,258 | -5,446 | -12,315 | -15,640 |
Net Income | -12,349 | -5,296 | -12,247 | -15,960 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,790 | -4,870 | -11,467 | -15,689 |
Cash | 14,847 | 3,316 | 7,030 | 14,008 |
Basic Shares | 1,027 | 751 | 442 | 333 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.99 |
2025-03-31 | -$8.45 |
2024-12-31 | -$6.29 |
2024-09-30 | -$2.05 |
